Ottawa – The Government of Canada is committed to advancing the development of new treatments and tools with the potential to save lives, improve health outcomes, and strengthen Canada’s capacity for future innovation. To make sure health products in Canada are safe and effective, they must first be evaluated through clinical trials. Mark Holland, Minister of Health, announced that the …
Government of Canada also announces that Aramis Biotechnologies secured the assets needed to maintain, improve and expand Medicago’s plant-based technology platform in Canada that will enhance pandemic preparedness capabilities Québec – Following the cessation of Medicago’s operations by its parent company Mitsubishi Chemical Group Corporation (“MCG”) in February 2023, the Government of Canada’s objectives were threefold: maintain Medicago’s intellectual property …
Investment in Pharmascience Inc. to increase domestic production capacity Candiac – The Government of Canada, and the Government of Quebec, are investing in the revitalization of the Canadian biomanufacturing and life sciences sector with projects that strengthen our capabilities, while boosting the economy and creating or maintaining hundreds of well-paying jobs. Soraya Martinez Ferrada, Minister responsible for the Economic Development …
Accelerator and nuclear reactors, in partnership with First Nations and biomanufacturing, to receive up to $35 million to support the development, production, advancement and distribution of medical isotopes used in fight against cancer and in diagnostic imaging Tiverton – The Government of Canada continues to deliver on its promise to rebuild and strengthen the biomanufacturing and life sciences sector across …
